News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Crude Oil Short-Term Surge Adds Volatility; Nasdaq and S&P Hit New Highs; Tesla Earnings Beat Expectations (April 23, 2026)2Tesla 2026 Q1 Earnings Highlights: Revenue Grows 16% – Highest Growth Rate in Nearly Three Years, Gross Margin Rises to 21.1%, Free Cash Flow More Than Doubles and Beats Expectations3Gold Trading Reminder: Iran's Strait of Hormuz "Ship Seizure" + Trump's "Fake Ceasefire" — Will Gold Prices Target 4,400 After Rebound Stalls?
KATNEW fluctuates 57.9% in 24 hours: Low-liquidity small-cap coin sees extreme pump, no clear catalyst
Bitget Pulse·2026/04/23 17:37
RTX (RateX) sees 79.8% volatility in 24 hours: price fluctuates sharply driven by high trading volume
Bitget Pulse·2026/04/23 17:12
US sanctions Cambodian senator alleged to be behind crypto scam centers as crackdown widens
The Block·2026/04/23 17:06
USD/JPY stabilizes near recent high amid Oil-driven inflation support
FXStreet·2026/04/23 17:00
Dow Jones Industrial Average treads water as semiconductors extend record streak
FXStreet·2026/04/23 16:57
ECB: Data-dependent path as Iran shock unfolds – Nomura
FXStreet·2026/04/23 16:03
MEZO 24-hour volatility reaches 40.6%: XT.com listing triggers short-term pump followed by correction
Bitget Pulse·2026/04/23 16:02
DUCK (DuckChain) fluctuated 86.6% in 24 hours: Low liquidity leads to drastic price swings
Bitget Pulse·2026/04/23 16:02
MAGMA (MAGMA) fluctuates 61.9% in 24 hours: abnormal trading volume and speculative pump drive the movement
Bitget Pulse·2026/04/23 16:02
Flash
17:46
All three major U.S. stock indexes fell, with the Dow Jones dropping below 49,000 points.The three major U.S. stock indices moved lower, with the Dow Jones Index falling below 49,000 points, latest at 49,000 points, down 1.01% for the day. The Nasdaq fell 1.4%, and the S&P 500 Index dropped 1.02%.
17:42
Brent crude oil rose by 4.5% intraday to $106.52 per barrel.WTI crude oil rose by $0.86 per barrel within 5 minutes, now at $97.49 per barrel.
17:26
The US biopharmaceutical company Grace Therapeutics Inc. recently disclosed that its core candidate drug, GTX-104, is under regulatory scrutiny involving several key issues.According to public information, the projects highlighted by regulators include research data on drug extractables, toxicological safety assessment reports, and deficiencies in the production process. Extractables data is directly related to the compatibility between drug packaging materials and formulations, serving as a key indicator for ensuring drug safety. Toxicological assessments are used to evaluate potential toxicity risks, and the integrity of both sets of data is crucial for drug approval. In addition, production deficiencies may affect the consistency and stability of drug quality. This round of regulatory attention is focused on the company's flagship product GTX-104, which is currently in a critical stage of development. Industry analysts point out that if these issues are not resolved in a timely manner, they could affect the drug’s review progress and final market launch schedule.
News